A key unanticipated finding is that the 19 insulinomas differ from the five beta-cell data sets with regard to the methylation status of the INS region, where the key beta-cell transcription factor, PDX1, binds, recruits other enhancer members, and transactivates INS gene expression. The gene discussed is PDX1; the disease is pancreatic insulinoma.